Posts by: Leonor Mateus Ferreira

Leonor Mateus Ferreira

Leonor Mateus Ferreira is an emerging, young journalist, with a Batchelor's degree in Communication and post-graduate degree in Multiplatform Journalism. She is particularly interested in politics and current affairs, and is currently studying for a masters degree in economics and public policies.

December 19, 2014December 19, 2014

Engineer and Surgeon Partner Up to Study Air Pollution Effects on Lung Transplant Patients

Bronchiolitis, News

Civil and Environmental Engineering Professor Jamie Schauer is traveling the country to study air quality and advocate for how air pollution negatively affects human health. Part of his campaign involves highlighting the importance ... Read more

December 17, 2014November 6, 2015

Dynavax and AstraZeneca Partner to Advance Asthma Therapy Study

Asthma, News

Dynavax Technologies Corp and AstraZeneca AB have signed an amendment regarding the Research Collaboration and License Agreement they had previously established. The partnership stipulates that AstraZeneca will be responsible for the financial support of ... Read more

December 17, 2014November 11, 2015

COPD Management System Awarded $1,500,000 by UK Government

COPD, News

HealthQuest Solutions was granted a £960,000 ($1,500,000) Small Business Research Initiative (SBRI) award from the United Kingdom to support the development of the company’s myCOPD Solution. The system is designed to improve ... Read more

December 16, 2014December 16, 2014

FDA Extends Cyramza Approval to Metastatic Non-small Cell Lung Cancer

Lung Cancer, News

The U.S. Food and Drug Administration (FDA) has expanded the use of Cyramza (ramucirumab) to include patients suffering from metastatic non-small cell lung cancer (NSCLC) — the most common type of lung cancer — ... Read more

December 15, 2014December 15, 2014

Pfizer Lung Cancer Targeted Therapy More Effective than Chemotherapy on Trial

Lung Cancer, News

Patients suffering from lung cancer that was previously untreated and who have experienced changes in the anaplastic lymphoma kinase (ALK) gene can benefit more from a new targeted treatment development by Pfizer than from ... Read more

December 15, 2014November 6, 2015

Asthma Attacks Caused by Colds May be Reduced with New Blood Tests

Asthma, News

Patients suffering from asthma and chronic obstructive pulmonary disease (COPD) who are more susceptible to be infected with the rhinoviruses that cause colds or severe flare-ups due to colds may be now ... Read more

December 12, 2014November 5, 2015

GSK Submits Ambrisentan for PAH Treatment to European Medicines Agency

News, Pulmonary Hypertension

Research-based pharmaceutical and healthcare company GSK has completed regulatory submission to the European Medicines Agency (EMA) regarding a series of Marketing Authorizations for ambrisentan (Volibris), their therapy for pulmonary arterial hypertension (PAH). ... Read more

December 11, 2014November 5, 2015

CFFT Supports Shire in Developing Cystic Fibrosis Technology Platform

Cystic Fibrosis, News

Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the non-profit drug discovery and development affiliate of the Cystic Fibrosis Foundation (CFF), and Shire, a specialty biopharmaceutical company, have established a partnership for ... Read more

December 9, 2014October 28, 2015

African Americans More Susceptible to Lung Cancer

Lung Cancer, News

Christopher S. Lathan, M.D. from the Dana-Farber Cancer Institute recently explained in a press release how lung cancer, the deadliest cancer among all Americans, affects African Americans differently from other racial groups. Lathan ... Read more

December 4, 2014November 5, 2015

FDA Approves PulmoFlow’s CF Combined Therapy of Drug and Nebulizer

Cystic Fibrosis, News

The U.S. Food and Drug Administration (FDA) has announced that Kitabis Pak, a co-packaging of generic tobramycin inhalation solution with the PARI LC PLUS Nebulizer developed by PulmoFlow, Inc. has been granted final approval. ... Read more